bioAffinity Technologies announced a collaboration with Pictor to develop next‑generation, high‑throughput diagnostics for asthma and COPD.Key Highlights:Original SEC Filing: bioAffinity Technologies, Inc. [ BIAF ] - 8-K - Jul. 22, 2026This is an AI-powered summary. It may contain inaccuracies. Con…
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing early-stage cancer diagnostics and targeted therapeutics, today announced a collaboration with Pictor®, Inc., a targeted proteomic platform company, to support development and commercialization of bioAffinity Te…
bioAffinity Technologies reported sharply higher CyPath® Lung unit sales and a partnership with Philips to enhance lung cancer screening for U.S. veterans.Key Highlights:Original SEC Filing: bioAffinity Technologies, Inc. [ BIAF ] - 8-K - Jun. 30, 2026This is an AI-powered summary. It may contain i…
NEW YORK CITY, NY / ACCESS Newswire / June 30, 2026 / Investor Summit Group is excited to share that the presentations from our Q2 Virtual Conference are now available on-demand. If you missed the live event, now's your chance to catch up at your own pace.Held on June 24, the summit featured an ana…
